Hinge Health Inc. (NYSE:HNGE - Get Free Report)'s stock price was down 6.1% on Wednesday . The stock traded as low as $43.60 and last traded at $44.07. Approximately 478,065 shares traded hands during mid-day trading, a decline of 47% from the average daily volume of 895,084 shares. The stock had previously closed at $46.92.
Analysts Set New Price Targets
A number of equities analysts have issued reports on the stock. Barclays started coverage on shares of Hinge Health in a research report on Monday, June 16th. They set an "overweight" rating and a $43.00 price target for the company. Royal Bank Of Canada started coverage on shares of Hinge Health in a report on Monday, June 16th. They set an "outperform" rating and a $45.00 target price for the company. Truist Financial initiated coverage on shares of Hinge Health in a research report on Monday, June 16th. They set a "buy" rating and a $48.00 target price for the company. Morgan Stanley started coverage on Hinge Health in a research report on Monday, June 16th. They set an "overweight" rating and a $46.00 price target on the stock. Finally, Bank of America began coverage on Hinge Health in a research note on Monday, June 16th. They set a "buy" rating and a $42.00 price objective for the company. One equities research analyst has rated the stock with a hold rating and thirteen have given a buy rating to the stock. Based on data from MarketBeat.com, Hinge Health presently has an average rating of "Moderate Buy" and a consensus price target of $46.00.
Check Out Our Latest Stock Analysis on Hinge Health
Hinge Health Stock Performance
About Hinge Health
(
Get Free Report)
Our vision is to build a new health system that transforms outcomes, experience and costs by using technology to scale and automate the delivery of care. Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Hinge Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hinge Health wasn't on the list.
While Hinge Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
